Novavax
NVAX
128 hedge funds and large institutions have $132M invested in Novavax in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 9 closing their positions.
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
27% more call options, than puts
Call options by funds: $1.23M | Put options by funds: $964K
15% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 34
2% more funds holding
Funds holding: 126 → 128 (+2)
0.21% less ownership
Funds ownership: 2.17% → 1.96% (-0.21%)
7% less capital invested
Capital invested by funds: $141M → $132M (-$9.7M)
Top Buyers
| 1 |
Millennium Management
New York
|
+$4.46M |
| 2 |
BlackRock
New York
|
+$1.89M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.71M |
| 4 |
Renaissance Technologies
New York
|
+$1.64M |
| 5 |
JP Morgan Chase
New York
|
+$1.12M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8M |
| 2 |
D.E. Shaw & Co
New York
|
-$5.67M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.11M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$971K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$934K |
NVAX Hedge Fund Activity: Q3 2017 in Review
128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2017, worth a combined $132M — down 6.9% from $141M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NVAX positions and 9 closed out — a net gain of 3 holders — while 39 added to existing stakes and 34 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.46M. The largest seller was Fidelity Investments, cutting an estimated $8M.
- 128 institutional investors held Novavax (NVAX) as of Q3 2017, up from 126 in Q2 2017.
- Funds reported $132M of Novavax stock for Q3 2017, down 6.9% quarter-over-quarter.
- 12 funds opened new Novavax positions in Q3 2017 and 9 closed out, a net change of +3 holders.
- The largest Novavax buyer in Q3 2017 was Millennium Management, an estimated $4.46M added.
- The largest Novavax seller in Q3 2017 was Fidelity Investments, an estimated $8M sold.
Based on aggregated 13F filings for Q3 2017.